These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27981549)

  • 21. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].
    Lin MX; Wen ZF; Feng ZY; He D
    Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma.
    Perisanidis C; Perisanidis B; Wrba F; Brandstetter A; El Gazzar S; Papadogeorgakis N; Seemann R; Ewers R; Kyzas PA; Filipits M
    J Oral Pathol Med; 2012 Jan; 41(1):40-6. PubMed ID: 21883486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.
    Miyabe S; Okabe M; Nagatsuka H; Hasegawa Y; Inagaki A; Ijichi K; Nagai N; Eimoto T; Yokoi M; Shimozato K; Inagaki H
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1432-41. PubMed ID: 19531414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.
    Rosati G; Chiacchio R; Reggiardo G; De Sanctis D; Manzione L
    Tumour Biol; 2004; 25(5-6):258-63. PubMed ID: 15627889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications.
    Antonescu CR; Leung DH; Dudas M; Ladanyi M; Brennan M; Woodruff JM; Cordon-Cardo C
    Am J Pathol; 2000 Mar; 156(3):977-83. PubMed ID: 10702413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p27Kip1 is inactivated in human colorectal cancer by cytoplasmic localization associated with activation of Akt/PKB.
    Bottini C; Platini F; Rinaldi M; Leutner M; Alabiso O; Garavoglia M; Tessitore L
    Int J Oncol; 2009 Jan; 34(1):69-77. PubMed ID: 19082479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of DCC and p27Kip1 in colorectal cancer.
    Wu JT; Kakar S; Nelson RL; Mihalov ML; Hayward B; Gilbert PB; Ghosh L
    Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):45-54. PubMed ID: 15722793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between Ki67 Index and Clinicopathological Features in Colorectal Cancer.
    Li P; Xiao ZT; Braciak TA; Ou QJ; Chen G; Oduncu FS
    Oncol Res Treat; 2016; 39(11):696-702. PubMed ID: 27855388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor.
    Quintanilla-Martinez L; Thieblemont C; Fend F; Kumar S; Pinyol M; Campo E; Jaffe ES; Raffeld M
    Am J Pathol; 1998 Jul; 153(1):175-82. PubMed ID: 9665478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controversial relationship between the expression of the RB pathway components and RB protein phosphorylation in human breast cancer.
    Montanaro L; Vici M; Donati G; Ceccarelli C; Santini D; Treré D; Derenzini M
    Histol Histopathol; 2007 Jul; 22(7):769-75. PubMed ID: 17455150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutoff of 25% for Ki67 expression is a good classification tool for prognosis in colorectal cancer in the AJCC‑8 stratification.
    Tong G; Zhang G; Liu J; Zheng Z; Chen Y; Niu P; Xu X
    Oncol Rep; 2020 Apr; 43(4):1187-1198. PubMed ID: 32323802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.
    Feldt M; Bjarnadottir O; Kimbung S; Jirström K; Bendahl PO; Veerla S; Grabau D; Hedenfalk I; Borgquist S
    J Transl Med; 2015 Apr; 13():133. PubMed ID: 25925673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the expression of cyclin-dependent kinase inhibitor p27Kip1 and apoptosis in tumor cells on the overall survival of patients with non-early stage gastric carcinoma.
    Ohtani M; Isozaki H; Fujii K; Nomura E; Niki M; Mabuchi H; Nishiguchi K; Toyoda M; Ishibashi T; Tanigawa N
    Cancer; 1999 Apr; 85(8):1711-8. PubMed ID: 10223564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
    Xi HQ; Zhao P
    J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ER, PgR, Ki67, p27(Kip1), and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide concomitant with trastuzumab.
    Kurozumi S; Inoue K; Takei H; Matsumoto H; Kurosumi M; Horiguchi J; Takeyoshi I; Oyama T
    BMC Cancer; 2015 Sep; 15():622. PubMed ID: 26345461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Independent Correlation Between Ki67 Index and Circulating Tumor Cells in the Diagnosis of Colorectal Cancer.
    Yang Y; Li J; Jin L; Wang D; Zhang J; Wang J; Zhao X; Wu G; Yao H; Zhang Z
    Anticancer Res; 2017 Aug; 37(8):4693-4700. PubMed ID: 28739773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma.
    Shapira M; Ben-Izhak O; Linn S; Futerman B; Minkov I; Hershko DD
    Cancer; 2005 Apr; 103(7):1336-46. PubMed ID: 15717322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.